Introduction
used to treat asthma have provided important insights into disease mechanisms. Colin Dollery has made important contributions to this field in pioneering the Asthma is one of the commonest diseases in industrialized countries and there is convincing evidence to clinical pharmacology approach, leading to greater understanding of adrenergic and neural mechanisms of suggest that its prevalence and morbidity are increasing, despite better recognition and increased prescriptions asthma and the role of inflammatory mediators, such as leukotrienes and prostaglandins. for anti-asthma therapy. It is somewhat paradoxical that the morbidity and mortality of asthma should be Our views on asthma have changed in the last decade, with the recognition that chronic inflammation underlies increasing at a time when there is increased understanding of the pathophysiology of asthma and when effective the clinical syndrome. In the past it was assumed that the basic defect in asthma lay in abnormal contractility therapies are available; it points to the need for even better understanding of the underlying mechanisms of airway smooth muscle, giving rise to variable airflow obstruction, and the common symptoms of intermittent involved in asthma and elucidation of the mode of action of currently available anti-asthma therapies.
wheeze and shortness of breath. However studies of airway smooth muscle from asthmatic patients have Clinical pharmacology has made important contributions to our understanding of asthma, since drugs shown no convincing evidence for increased contractile responses to spasmogens such as histamine in vitro, such as mediator antagonists have elucidated the underlying inflammatory mechanisms and the drugs indicating that asthmatic airway smooth muscle is not fundamentally abnormal and suggesting that it is the asthma is a chronic inflammatory disease, with inflammation persisting over many years in most patients. control of airway calibre in vivo which is abnormal.
For many years it has been assumed that mast cells Superimposed on this chronic inflammatory state are acute inflammatory episodes which correspond to play a critical role in asthma and that mast cell mediators produce the pathophysiology of asthma.
exacerbations of asthma. It is clearly important to understand the mechanisms of acute and chronic More recently it has become clear that many different inflammatory cells are activated in asthmatic airways, inflammation in asthmatic airways and to investigate the long-term consequences of this chronic inflammation and that these cells produce a variety of mediators which act in a complex manner on target cells of the on airway function. It is also important to consider the effects of therapy on the inflammatory process. airways to produce the abnormal pathophysiological features typical of asthma. Recent research has established that asthma, even in its mildest clinical forms, involves a special type of inflammation in the airways.
Inflammatory cells
Many different inflammatory cells are involved in asthma, although the precise role of each cell type is Asthma as an inflammatory disease not yet certain [3, 4] . It is evident that no single inflammatory cell is able to account for the complex It had been recognised for many years that patients who die of asthma attacks have grossly inflamed pathophysiology of asthma, but some cells are predominant in asthmatic inflammation. airways. The airway lumen is occluded by a tenacious mucus plug composed of plasma proteins exuded from Mast cells are clearly important in initiating the acute responses to allergen and probably to other indirect airway vessels and mucus glycoproteins secreted from surface epithelial cells. The airway wall is oedematous stimuli, such as exercise and hyperventilation (via osmolality or thermal changes) and fog. However there and infiltrated with inflammatory cells, which are predominantly eosinophils and lymphocytes. The airway are questions about the role of mast cells in more chronic inflammatory events, and it seems more probable epithelium is invariably shed in a patchy manner and clumps of epithelial cells are found in the airway lumen.
that other cells such as macrophages, eosinophils and T-lymphocytes are more important in the chronic Occasionally there have been opportunities to examine the airways of asthmatic patients who die accidentally inflammatory process, including AHR. Macrophages, which are derived from blood monoand similar though less marked inflammatory changes have been observed [ 1] . More recently it has been cytes, may traffic into the airways in asthma and may be activated by allergen via low affinity IgE receptors possible to examine the airways of asthmatic patients by fibreoptic and rigid bronchoscopy, by bronchial [5 ] . The enormous repertoire of macrophages allows these cells to produce many different products, including biopsy and by bronchoalveolar lavage (BAL ). Direct bronchoscopy reveals that the airways of asthmatic a large variety of cytokines which may orchestrate the inflammatory response. Macrophages therefore have the patients are often reddened and swollen, indicating acute inflammation. Lavage has revealed an increase in capacity to initiate a particular type of inflammatory response via the release of a certain pattern of cytokines. the numbers of lymphocytes, mast cells and eosinophils and evidence for activation of macrophages in compariMacrophages may both increase and decrease inflammation, depending on the stimulus. Alveolar macroson with non-asthmatic controls. Biopsies have revealed evidence for increased numbers and activation of mast phages normally have a suppressive effect on lymphocyte function, but this may be impaired in asthma after cells, macrophages, eosinophils and T-lymphocytes [2] . These changes are found even in patients with mild allergen exposure [6] . Macrophages may therefore play an important anti-inflammatory role, preventing the asthma who have few symptoms, and this suggests that asthma is an inflammatory condition of the airways. development of allergic inflammation. Macrophages may also act as antigen-presenting cells which process The relationship between inflammation and clinical symptoms of asthma is not clear. There is evidence that allergen for presentation to T-lymphocytes, although alveolar macrophages are far less effective in this respect the degree of inflammation is related to airway hyperresponsiveness (AHR), as measured by histamine or than macrophages from other sites, such as the peritoneum [ 7] . By contrast dendritic cells which are methacholine challenge. Increased airway responsiveness is an exaggerated airway narrowing in response to many specialised macrophage-like cells in the airway epithelium, are very effective antigen-presenting cells [7 ] , stimuli which is characteristic of asthma and the degree of AHR relates to asthma symptoms. Inflammation of and may therefore play a very important role in the initiation of allergen-induced responses in asthma. the airways may increase airway responsiveness which thereby allows triggers which would not narrow the Eosinophil infiltration is a characteristic feature of asthmatic airways and differentiates asthma from other airways to do so. But inflammation may also directly lead to an increase in asthma symptoms, such as cough inflammatory conditions of the airway. Indeed, asthma might more accurately be termed 'chronic eosinophilic and chest tightness, by activation of airway sensory nerve endings.
bronchitis' (a term first used in 1916!). Allergen inhalation results in a marked increase in eosinophils in bronchoalAlthough most attention has been focused on the acute inflammatory changes seen in asthmatic airways, veolar lavage fluid at the time of the late reaction, and there is a close relationship between eosinophil counts T-lymphocytes play a very important role in co-ordinating the inflammatory response in asthma in peripheral blood or bronchial lavage and AHR. Eosinophils were originally viewed as beneficial cells in through the release of specific patterns of cytokines, resulting in the recruitment and survival of eosinophils asthma, as they have the capacity to inactivate histamine and leukotrienes, but it now seems more likely that they and in the maintenance of mast cells in the airways. T-lymphocytes are coded to express a distinctive pattern may play a damaging role, and may be linked to the development of airway hyperresponsiveness through the of cytokines, which may be similar to that described in the murine Th2 type of T-lymphocytes, which characterrelease of basic proteins and oxygen-derived freeradicals [8] .
istically expresses IL-3, IL-4 and IL-5 [18 ] . This programming of T-lymphocytes is presumably due to An important area of research is now concerned with the mechanisms involved in recruitment of eosinophils antigen presenting cells such as dendritic cells, which may migrate from the epithelium to regional lymph into asthmatic airways. Eosinophils are derived from bone marrow precursors. After allergen challenge eosinonodes or which interact with lymphocytes resident in the airway mucosa. phils appear in BAL fluid during the late response, and this is associated with a decrease in peripheral eosinophil counts and with the appearance of eosinophil progenitors in the circulation. The signal for increased eosinophil Epithelial cells production is presumably derived from the inflamed airway. Eosinophil recruitment initially involves Epithelial cells also produce inflammatory mediators, such as endothelins, proinflammatory cytokines, chemoadhesion of eosinophils to vascular endothelial cells in the airway circulation, their migration into the submukines and growth factors [19] . Epithelial cells may play a key role in translating inhaled environmental cosa and their subsequent activation. The role of individual adhesion molecules, cytokines and mediators signals into an airway inflammatory response and are probably the main target cell for inhaled glucoin orchestrating these responses has yet to be clarified. Adhesion of eosinophils involves the expression of corticoids. specific glycoprotein molecules on the surface of eosinophils (integrins) and their expression of such molecules as intercellular adhesion molecule-1 (ICAM-1 ) on vascular endothelial cells. An antibody directed at Inflammatory mediators ICAM-1 markedly inhibits eosinophil accumulation in the airways after allergen exposure and also blocks the Many different mediators have been implicated in asthma and they may have a variety of effects on the accompanying hyperresponsiveness [9] . However ICAM-1 is not selective for eosinophils and cannot airways which could account for the pathological features of asthma [ 20, 21] . Mediators such as account for the selective recruitment of eosinophils in allergic inflammation. The adhesion molecules VLA4 histamine, prostaglandins and leukotrienes contract airway smooth muscle, increase microvascular leakage, expressed on eosinophils and vascular cell adhesion molecule-1 (VCAM-1) appear to be more selective for increase airway mucus secretion and attract other inflammatory cells. Because each mediator has many eosinophils [10 ] and interleukin-4 (IL-4) increases the expression of VCAM-1 on endothelial cells [11] .
effects the role of individual mediators in the pathophysiology of asthma is not yet clear. Indeed the Eosinophil migration may be due to the effects of platelet anticoating factor (PAF), which is selectively multiplicity of mediators makes it unlikely that antagonising a single mediator will have a major chemoattractant to eosinophils [ 12] , and to the effects of cytokines such as GM-CSF, IL-3 and IL-5 [13] .
impact in clinical asthma. The cysteinyl-leukotrienes LTC 4 , LTD 4 and LTE 4 are These cytokines may be very important for the survival of eosinophils in the airways and may 'prime' eosinophils potent constrictors of human airways and have been reported to increase AHR and may play an important to exhibit enhanced responsiveness. Eosinophils from asthmatic patients show greatly exaggerated responses role in asthma [22 ] . The recent development of potent specific leukotriene antagonists has made it possible to to PAF and phorbol esters, than eosinophils from atopic non-asthmatic individuals [ 14] and this is further evaluate the role of these mediators in asthma. Potent LTD 4 antagonists protect (by about 50%) against increased by allergen challenge [15 ] , suggesting that they may have been primed by exposure to cytokines in exercise- [ 23] and allergen-induced bronchoconstriction [24 ] , suggesting that leukotrienes contribute to bronchthe circulation. There are several mediators involved in the migration of eosinophils from the circulation to oconstrictor responses. Chronic treatment with leukotriene antagonists improve lung function and symptoms the surface of the airway. The most potent and selective agents appear to be chemokines, such as RANTES, in asthmatic patients, although the degree of improvement is modest compared with what would be expected that is expressed in epithelial cells [16 ] , and eotaxin [ 17 ] .
The role of neutrophils in human asthma is less clear. of an inhaled glucocorticoid [25 ] . The role of leukotrienes in chronic asthma remains to be defined and Neutrophils are found in the airways of chronic bronchitics and patients with bronchiectasis who do not several clinical trials with potent antagonists are currently underway. have the degree of AHR found in asthma, but there is increasing evidence that neutrophils may be important A mediator which has attracted considerable attention recently is PAF, since it mimics many of the features of in acute exacerbations of asthma.
asthma, including AHR [12]. Although PAF appears
Nitric oxide to be produced by the inflammatory cells involved in asthmatic inflammation and mimics many of the Nitric oxide (NO) is produced by several cells in the airway by NO synthases (NOS) [32 ] . An inducible pathophysiological features of asthma, its role in asthma will only become apparent with the use of potent and form of the enzyme (iNOS) is expressed in epithelial cells of asthmatic patients [ 33] and can be induced by specific antagonists. Initial results with potent PAF antagonists such as apafant (WEB 2086 ) and modipafant cytokines in airway epithelial cells [ 34] . This may account for the increased concentration of NO in the in chronic asthma have been disappointing, however [26, 27 ] .
exhaled air of asthmatic patients [35 ] . NO itself is a potent vasodilator and this may increase plasma exudation in the airways; it may also amplify the Th2-lymphocyte mediated response [36] . Cytokines Cytokines are increasingly recognised to be important in chronic inflammation and play a critical role in Effects of inflammation orchestrating the type of inflammatory response. Many inflammatory cells (macrophages, mast cells, eosinophils
The chronic inflammatory response has several effects on the target cells of the airways, resulting in the and lymphocytes) are capable of synthesising and releasing these proteins, and structural cells such as characteristic pathophysiological changes associated with asthma. Important advances have recently been epithelial cells and endothelial cells may also release a variety of cytokines and may therefore participate in made in understanding these changes, although their role in asthma symptoms is often not clear. the chronic inflammatory response [13] . While inflammatory mediators like histamine and leukotrienes may be important in the acute and subacute inflammatory responses and in exacerbations of asthma, it is likely Airway epithelium that cytokines play a dominant role in chronic inflammation. Almost every cell is capable of producing Airway epithelial shedding may be important in contributing to airway hyperresponsiveness and may explain cytokines under certain conditions. Research in this area is hampered by a lack of specific antagonists, although how several different mechanisms, such as ozone exposure, certain virus infections, chemical sensitisers and important observations have been made using specific neutralising antibodies. The cytokines which appear to allergen exposure, can lead to its development, since all these stimuli may lead to epithelial disruption. be of particular importance in asthma include the lymphokines secreted by T-lymphocytes: IL-3, which is Epithelium may be shed as a consequence of inflammatory mediators, such as eosinophil basic proteins and important for the survival of mast cells in tissues, IL-4 which is critical in switching B-lymphocytes to produce oxygen-derived free radicals, together with various proteases released from inflammatory cells. Epithelial IgE and for expression of VCAM-1 on endothelial cells, IL-5 which is of critical importance in the differentiation, cells are commonly found in clumps in the BAL or sputum (Creola bodies) of asthmatics, suggesting that survival and priming of eosinophils. There is evidence for increased gene expression of IL-5 in lymphocytes in there has been a loss of attachment to the basal layer or basement membrane. Epithelial damage may contribbronchial biopsies of patients with symptomatic asthma [28 ] . Other cytokines, such as IL-1, IL-6, tumour ute to AHR in a number of ways, including loss of its barrier function to allow penetration of allergens, loss necrosis factor-a (TNF-a) and GM-CSF are released from a variety of cells, including macrophages and of enzymes (such as neutral endopeptidase) which normally degrade inflammatory mediators, loss of a epithelial cells, and may be important in amplifying the inflammatory response. TNF-a may be an important relaxant factor (so called epithelial-derived relaxant factor), and exposure of sensory nerves which may lead amplifying mediator in asthma and is produced in increased amounts in asthmatic airways. Inhalation of to reflex neural effects on the airway. TNF-a increased airway responsiveness in normal individuals [29] .
Subepithelial fibrosis
An apparent increase in the basement membrane has been described in fatal asthma, although similar changes Endothelins have been described in the airways in other conditions [1 ] . Electron microscopy of bronchial biopsies in Endothelins are potent peptide mediators that are potent vasoconstrictors and bronchoconstrictors [30] .
asthmatic patients demonstrates that this thickening is due to subepithelial fibrosis [ 2] . Type III and V collagen They also induce airway smooth muscle cell proliferation and fibrosis and may therefore play a role in the chronic appear to be laid down, and may be produced by myofibroblasts which are situated under the epithelium. inflammation of asthma. There is evidence for increased expression of endothelins in asthma, particularly in
The mechanism of fibrosis is not yet clear but several cytokines, including TGFb and platelet derived growth airway epithelial cells [ 31] .
factor (PDGF) may be produced by epithelial cells or contributes to the viscid mucus plugs which occlude asthmatic airways, particularly in fatal asthma. There is macrophages in the inflamed airway [ 13] .
evidence for hyperplasia of submucosal glands which are confined to large airways and of increased numbers of epithelial goblet cells. This increased secretory Airway smooth muscle response may be due to inflammatory mediators acting There is still debate about the role of abnormalities in on submucosal glands and due to stimulation of neural airway smooth muscle in asthmatic airways. In vitro elements. Little is understood about the control of airway smooth muscle from asthmatic patients usually goblet cells, which are the main source of mucus in shows no increased responsiveness to spasmogens. peripheral airways, although recent studies investigating Reduced responsiveness to b-adrenoceptor agonists has the control of goblet cells in guinea pig airways suggest also been reported in post-mortem or surgically removed that cholinergic, adrenergic and sensory neuropeptides bronchi from asthmatics, although the number of are important in stimulating secretion [ 42] . b-receptors is not reduced, suggesting that b-receptors have been uncoupled [37] . These abnormalities of airway smooth muscle may be a reflection of the chronic inflammatory process. For example the reduced
Neural effects b-adrenergic responses in airway smooth muscle could be due to phosphorylation of the stimulatory G-protein There has recently been a revival of interest in neural coupling b-receptors to adenylyl cyclase, resulting from mechanisms in asthma [43] . Autonomic nervous control the activation of protein kinase C by the stimulation of of the airways is complex, for in addition to classical airway smooth muscle cells by inflammatory mediators cholinergic and adrenergic mechanisms, non-adrenergic [38] .
non-cholinergic (NANC) nerves and several neuropepIn asthmatic airways there is also a characteristic tides have been identified in the respiratory tract [44 ] . hypertrophy and hyperplasia of airway smooth muscle Several studies have investigated the possibility that [39 ], which is presumably the result of stimulation of defects in autonomic control may contribute to airway airway smooth muscle cells by various growth factors, hyperresponsiveness and asthma, and abnormalities of such as PDGF, or endothelin-1 released from inflammaautonomic function, such as enhanced cholinergic and atory cells.
adrenergic responses or reduced b-adrenergic responses, have been proposed. Current thinking suggests that these abnormalities are likely to be secondary to the Vascular responses disease, rather than primary defects [43 ] . It is possible that airway inflammation may interact with autonomic Vasodilatation occurs in inflammation, yet little is control by several mechanisms. known about the role of the airway circulation in Inflammatory mediators may act on various asthma, partly because of the difficulties involved in pre-junctional receptors on airway nerves to modulate measuring airway blood flow. The bronchial circulation the release of neurotransmitters [45 ] . Thus thrommay play an important role in regulating airway calibre, boxane and prostaglandin D 2 (PGD 2 ) facilitate the since an increase in the vascular volume may contribute release of acetylcholine from cholinergic nerves in to airway narrowing. Increased airway blood flow may canine airways, whereas histamine inhibits cholinergic be important in removing inflammatory mediators from neurotransmission at both parasympathetic ganglia and the airway, and may play a role in the development of post-ganglionic nerves via H 3 -receptors. Inflammatory exercise-induced asthma.
mediators may also activate sensory nerves, resulting in reflex cholinergic bronchoconstriction or release of inflammatory neuropeptides. Inflammatory products Plasma extravasation may also sensitise sensory nerve endings in the airway epithelium, so that the nerves become hyperalgesic. Microvascular leakage is an essential component of the inflammatory response and many of the inflammatory Hyperalgesia and pain (dolor) are cardinal signs of inflammation, and in the asthmatic airway may mediate mediators implicated in asthma produce this leakage [20, 40, 41 ] . There is good evidence for microvascular cough and dyspnoea, which are such characteristic symptoms of asthma. The precise mechanisms leakage in asthma and it may have several consequences on airway function, including increased airway of hyperalgesia are not yet certain, but mediators such as prostaglandins and certain cytokines may be secretions, impaired mucociliary clearance, formation of new mediators from plasma precursors (such as kinins) important. Bronchodilator nerves which are non-adrenergic are and mucosal oedema which may contribute to airway narrowing and increased airway hyperresponsiveness. prominent in human airways, and it has been suggested that these nerves may be defective in asthma [46 ] . In animal airways vasoactive intestinal peptide (VIP) has been shown to be a neurotransmitter of these nerves Mucus hypersecretion and a striking absence of VIP-immunoreactive nerves has been reported in the lungs from patients with severe Mucus hypersecretion is a common inflammatory response in secretory tissues. Increased mucus secretion fatal asthma [ 47] . However it is likely that this loss of VIP immunoreactivity is due to degradation by tryptase asthmatic patients have airway inflammation which leads to airway narrowing it would seem more approreleased from degranulating mast cells in the airways of asthmatics [48 ] . In human airways the bronchodilator priate to use anti-inflammatory treatment as first-line therapy [58 ] . For patients with mild asthma sodium neurotransmitter appears to be NO [49] .
Airway nerves may also release neurotransmitters cromoglycate or nedocromil sodium may be sufficient, but for many patients with asthma inhaled corticosterwhich have inflammatory effects. Thus neuropeptides such as substance P (SP), neurokinin A and calcitoninoids will be needed. Inhaled glucocorticoids are highly effective in controlling asthma and may work on many gene related peptide may be released from sensitised inflammatory nerves in the airways which increase and aspects of the chronic inflammatory response [59 ] . By contrast bronchodilators, such as b 2 -adrenoceptor agonextend the ongoing inflammatory response [50 ] . There is evidence for an increase in SP-immunoreactive nerves ists, may relieve the symptoms of asthma acutely, but fail to control the underlying chronic inflammatory in airways of patients with severe asthma [51 ] , which may be due to proliferation of sensory nerves and response. Indeed there is evidence to suggest that regular use of inhaled b 2 -adrenoceptor agonists may even increased synthesis of sensory neuropeptides as a result of nerve growth factors released during chronic inflamincrease AHR and chronic asthma symptoms [ 60] . It is now recommended that they should be used only for mation. There may also be a reduction in the activity of enzymes, such as neutral endopeptidase, which acute symptom control and that asthma should be controlled primarily with inhaled anti-inflammatory degrade neuropeptides such as SP [ 52] . There is also evidence for increased gene expression of the receptor agents. It is hoped that the earlier use of inhaled steroids may reduce the morbidity and mortality of asthma and which mediates the inflammatory effects of SP [ 53] . Thus chronic asthma may be associated with increased may also prevent the irreversible structural changes which may underlie the gradual decline in lung function neurogenic inflammation, which may provide a mechanism for perpetuating the inflammatory response even in seen in patients with poorly controlled asthma and there is some evidence to support this [61 ] . the absence of initiating inflammatory stimuli.
